![Varun Khurana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Varun Khurana
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Varun Khurana
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bausch & Lomb, Inc.
![]() Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
Northeast Louisiana University | College/University | Undergraduate Degree | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
InterveXion Therapeutics LLC
![]() InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Pharmaceuticals: Major | Chief Executive Officer | |
UNICYCIVE THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
The University of North Carolina at Chapel Hill | College/University | Doctorate Degree | |
Kuria Therapeutics, Inc.
![]() Kuria Therapeutics, Inc. BiotechnologyHealth Technology Kuria Therapeutics, Inc. is a company that focuses on the biology of NRF2, which is the body's master regulator of the cytoprotective, antioxidant, and detoxification response. The company is based in Little Rock, AZ. The company is developing a potent NRF2 activator for multiple ophthalmic and dermatologic conditions. The company was founded by Keith W. Ward, Misty Stevens. Keith W. Ward has been the CEO since incorporation. | Biotechnology | Chief Executive Officer | |
University of Pennsylvania | College/University | Undergraduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
Secord, Inc. | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 12 |
Sektoral
Health Technology | 7 |
Consumer Services | 5 |
Operativ
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Undergraduate Degree | 2 |
President | 2 |
Director/Board Member | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Keith Ward | 9 |
Rhea Williams | 4 |
- Börse
- Insiders
- Varun Khurana
- Unternehmensverbindungen